Breaking News Bar

Business News and Information

Alkermes depression drug in peril after FDA advisory vote

The advisory committee decision is not a final verdict on the drug application, but a negative decision is often a sign that the FDA will reject the drug.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear